Rare upper gastrointestinal hemorrhage of cetuximab: A case report

RATIONALE: cetuximab, an epidermal growth factor receptor inhibitor, is a targeted therapeutic regimen of colorectal cancers. Several common adverse effects have been found, such as cutaneous or gastrointestinal toxicity. However, according to the articles had been published, upper gastrointestinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Shi-Jie, Gao, Zi-Ming, Wang, Peng-Liang, Gong, Bao-Cheng, Huang, Han-Wei, Luo, Lei, Wang, Xin, Xing, Ya-Nan, Xu, Hui-Mian, Liu, Fu-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758247/
https://www.ncbi.nlm.nih.gov/pubmed/29390545
http://dx.doi.org/10.1097/MD.0000000000009391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758247/
https://www.ncbi.nlm.nih.gov/pubmed/29390545
http://dx.doi.org/10.1097/MD.0000000000009391

Ejemplares similares